New Personalized Medicine Data Have Been Reported by Sigrid Le Clerc and Co-Authors (Immunogenetic variants in major mental and neurodevelopmental disorders).

This article focuses on recent research from Paris, France, examining the role of immunogenetic variants in major mental disorders (MMDs) such as bipolar disorder, schizophrenia, recurrent depression, autism spectrum disorders, and attention-deficit/hyperactivity disorder. The study highlights how abnormal immune processes may cause chronic, low-grade inflammation in subsets of patients, contributing to poor prognosis and treatment resistance. It emphasizes the interaction between genetic immune factors and environmental risks, advocating for improved patient stratification and personalized therapeutic strategies based on immunogenetic profiles. The research underscores the importance of both innate and adaptive immunity genes, including associations identified by the Psychiatric Genomics Consortium in the major histocompatibility complex region. [Extracted from the article]